Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Procedure Type & Product The global facial implant market will witness a robust CAGR of 8.13%, valued at $2.53 billion in 2021, expected to appreciate and reach $5.11 billion by 2030, confirms Strategic Market Research. There will be an increase in sports-related facial injuries and the demand for minimally invasive surgery to repair facial trauma during the forecast period. An increase in demand is attributed to several factors, including healthcare expenditures, knowledge of facial implants, and cosmetic surgery adoption. The purpose of facial implants is to correct the facial structure or enhance the face's features such as cheeks, the chin, and the jawline. In addition to cosmetic purposes, facial implants are also used for medical emergencies such as injuries and accidents. These implants can also be used for augmentation or reconstruction of the face. Facial implants give long-lasting and permanent results that are crucial in the rise in cosmetic facial implant procedures. Facial implants come in various shapes, sizes, and materials. The person's anatomy determines this type of facial implant. Synthetic materials and biomaterials are used to prepare facial implants and are available in various sizes and shapes. Facial implants come in anatomical, oval, and round shapes used in chin augmentation, maxilla, and mandibular surgeries. Different facial implants includeChin implants, Jaw implants, Cheek implants, dermal fillers, Blepharoplasty, Facial Liposuction, Fat Transfer, Hair Restoration, Laser Facial Resurfacing, Otoplasty, Perioral Rejuvenation, Rhinoplasty. Market Drivers: Social media's growing influence and celebrities' influence on the youthswill drive the growth of the market. In addition, it is estimated that cosmetic surgery will increase as personal appearance becomes a more critical concern for the general population in both developed and developing economies. Other factors which will drive the market include a rise in road accidents, trauma cases, and congenital face deformities, and youths are motivated by celebrities to improve their aesthetics. New products need to get regulatory approval before being released on the Facial implant market. The FDA approved Oxford Performance Materials, Inc.'s 3D printed facial implant in 2015, which presents a market opportunity for players in the sector. Face implant surgery is expected to increase rapidly due to growing awareness about the Procedure and the high adoption among celebrities. Market Restraint: Facial implant procedures are complicated by surgical complications; the low success rate of facial implants, excessive bleeding during and after the surgery and Postoperative blood clotnegatively affect the market's growth rate. Market Analysis of Different Segments Covered in the Report By Material: The increasing use of polymer implants for deformity correction procedures contributed to the highest revenue share in 2020. The market growth will also be accelerated by its benefits, such as rigid support, flexibility, and biocompatibility. In addition, silicone implants are regularly used in augmentation surgeries. Contrary to this, biological materials are predicted to grow faster due to their similarity to the body tissues, making them more readily adopted. Therefore, the near future should also increase facial implant penetration as more money is invested in researching and developing biocompatible implants. By Procedure Facelift Surgery Eyelid Surgery Rhinoplasty It is expected that injectables or fillers will experience significant growth of over 7.8% during the next seven years as a result of a growing demand for non-surgical facial rejuvenation procedures, high cost-effectiveness, and widespread awareness about the benefits of fillers for augmentation procedures. Statistical data published by American Society of Plastic Surgeons (ASPS) indicate that in 2020, the facelift and eyelid surgery were the top cosmetic surgery procedures performed in the U.S.In addition, based on 2020 data, the revenue share of botulinum toxin Type A accounted for over 33.1 percent of all fillers in the United States. By Product Cheek Chin & Mandibular Nasal Injectables As facial surgeries become more common, the global market for procedural implants should grow. The increase in aesthetic eyelid surgeries attributed to removing extra skin from the eyelids, reducing bagginess, and correcting vision dominated the overall procedure segment. The American Society of Plastic Surgeons report states that in the year 2020, approximately 325,112 eyelid procedures and 234,374 face lift procedures were performed in the U.S. The number of these proceduresare expected to rise over the next five years as people's awareness of aesthetics, particularly among baby boomers, increases, adoption of facelift surgery is likely to increase in the next seven years. Regional Analysis: The North American market had the largest market share in 2020 at 37.8% due to a rising incidence of facial deformities caused by industrial development.Moreover, a technologically advanced facial implant has also been introduced along withsophisticated healthcare infrastructure for facial surgery, increased patient awareness, and the rise in demand for minimally invasive surgery contributing to themarket's growth. However, several factors drive the Asia Pacific market, including high untapped opportunities, increased patient awareness levels, and continuously improving healthcare infrastructure. Globally, the top five countries for cosmetic surgery and procedures performed in 2018 are the USA, Brazil, Mexico, Germany, and India, according to the International Society of Aesthetic Plastic Surgery (ISAPS). Surgical and non-surgical cosmetic procedures in the United States and Brazil made up 28.4% of all cosmetic procedures in 2018. Still, there were vast differences in the number of non-surgical treatments performed in USA and Brazil, such as Botox, fillers, and chemical peels. A total of 2.8 million cosmetic procedures were performed in USA, compared to 769,000 in Brazil - nearly three times the number of procedures performed in Brazil. According to ISAPS's annual survey, global demand for non-invasive treatments grew by 10.4% in 2018. Over the next seven years, medical tourism activities are expected to contribute to industry growth in emerging economies such as India and China, supported by low procedural costs. Facial Implant Market Competitive Landscape Analysis Integra LifeSciences Kangui Medical Innovation Co. Ltd. AART Inc. Anthony Products Inc Surgiform Technology Ltd. W.L. Gore & Associates, Inc. Stryker Corporation Spectrims Design Medicals Inc. Eurosurgical Ltd. Wanhe Plastic Materials Hanson Medical, Inc SientraIncKLS Martin L.P., DePuy Synthes Medartis AG Lucid Implants Johnson & Johnson TMJ Concepts Zimmer-Biomet Inc. OsteoMed Implantech Associates, Inc. Sebbin Facial Implant Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 2.53 Billion Revenue forecast in 2030 USD 5.11 Billion Growth rate CAGR of approximately 8.13% Base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Procedure, By Product, By Regions, By Procedure Facelift Surgery, Eyelid Surgery, Rhinoplasty By Product Cheek, Chin & Mandibular, Nasal, Injectables By Region North America, Europe, Asia Pacific, LAMEA Country Scope United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc. Company Usability Profiles Integra LifeSciences, Kangui Medical Innovation Co. Ltd., AART Inc., Anthony Products Inc, Surgiform Technology Ltd., W.L. Gore & Associates, Inc.. Stryker Corporation, Spectrims Design Medicals Inc., Eurosurgical Ltd., Wanhe Plastic Materials, Hanson Medical, Inc, SientraIncKLS Martin L.P., DePuy Synthes, Medartis AG, Lucid Implants, Johnson & Johnson, TMJ Concepts, Zimmer-Biomet Inc., OsteoMed, Implantech Associates, Inc. Sebbin. Recent Development: In November 2020, Lucid Implants inaugurated an advanced manufacturing facility to manufacture custom implants products. In September 2017, TRUMATCH Titanium 3D-Printed Implants for face reconstruction was released in the United States by DePuy Synthes. Materialise will be the exclusive distributor of the new products,who provides software solutions and 3D printing services to the healthcare and industrial sectors. The Essential Devices that Market Leaders Develop: Name of the Product Function Key Players Medpor It provides a variety of polyethylene solutions for reconstruction and augmentation. Stryker Corporation. Silicone Facial Implants These implants are made with implant grade silicone elastomer, meaning the implant is more supple and more durable, giving patients longer-lasting results Surgiform Eurosurgical Ltd. With the Vibrasat Pro liposuction cannula, the movement is reciprocated 2,8mm, assisting in the direction of the cannula and in the breakdown of fat and fibrous tissues. Additionally, the Liposat Infiltration pump and Vibrasat Handpiece may also be used with the NEW Vibrasat Pro for tumescent irrigation prior to liposuction. Vibrasat Pro Frequently Asked Question About This Report Which region is growing at the fastest growth rate in the market? Asia-Pacific region is estimated to have the highest growth rate worldwide. What is the facial implants market growth? The global facial implants market is expected to grow at a compound annual growth rate (CAGR) of 8.13% from 2021 to 2030 to reach USD 5.11 billion by 2030. What are the primary drivers of the market? Significant drivers of the market are the growing prevalence and incidence of neurological disorders, increasing knowledge about neurodegenerative ailments, increasing incidence of traumatic brain injury, Increasing usage of facial implants for trial purposes in the clinics, etc. How big is this facial implant market size ? The global facial implant market size was $2.53 Bn in 2021 and is predicted to reach $5.11 Bn by 2030, representing a CAGR of 8.13%. Who are the procedures covered in the market report? Based on the Procedure, the segments are divided into Eyelid Surgery, Facelift Surgery, and Rhinoplasty. Sources https://www.isaps.org/wp-content/uploads/2019/12/ISAPS-Global-Survey-2018-Press-Release-English.pdf https://www.cosmeticsurgerysolicitors.co.uk/news/countries-largest-number-cosmetic-surgeries https://www.cosmeticsurgerysolicitors.co.uk/news/countries-largest-number-cosmetic-surgeries 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Facial Implants market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by Region, 2021 - 2030 (USD Million) 4.4 Product Type Business Analysis 4.4.1 Global Market, By Product Type, 2021 - 2030 (USD Million) 4.5 Procedure Business Analysis 4.5.1 Global Market, By Procedure, 2021 - 2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Facial Implants Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Chin & Mandibular 7.3.1. Chin & Mandibular market, 2021 - 2030 (USD Million) 7.4. Cheek 7.4.1. Cheek market, 2021 - 2030 (USD Million) 7.5. Nasal 7.5.1. Nasal market, 2021 - 2030 (USD Million) 7.6. Injectables 7.6.1. Injectables market, 2021 - 2030 (USD Million) 8. Global Market: By Procedure Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Eyelid Surgery 8.3.1. Eyelid Surgery market, 2021 - 2030 (USD Million) 8.4. Facelift Surgery 8.4.1. Facelift Surgery market, 2021 - 2030 (USD Million) 8.5 Rhinoplasty 8.5.1 Rhinoplasty market, 2021 - 2030 (USD Million) 9. Global Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By Product Type, 2021 - 2030 (USD Million) 9.1.4. North America Market, By Procedure, 2021 - 2030 (USD Million) 9.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By Product Type, 2021 - 2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By Product Type, 2021 - 2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021 - 2030 (USD Million) 9.1.4.2.3. Canada Market, by Procedures, 2021 - 2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By Product Type, 2021 - 2030 (USD Million) 9.2.2. Europe Market, by By Procedure, 2021 - 2030 (USD Million) 9.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.1.2. U.K. Market, By Procedures, 2021 - 2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021 - 2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.2.2. Germany Market, By Procedure, 2021 - 2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021 - 2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021 - 2030 (USD Million) 9.2.4.3.3. France Market, by Procedure, 2021 - 2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By Product Type, 2021 - 2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021 - 2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, by Procedure, 2021 - 2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By Product Type, 2021 - 2030 (USD Million) 9.3.2. Asia Pacific Market, By Procedure, 2021 - 2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021 - 2030 (USD Million) 9.3.4.1.3. China Market, by Procedure, 2021 - 2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021 - 2030 (USD Million) 9.3.4.2.3. India Market, by Procedure, 2021 - 2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.3.3. Japan Market, by Procedure, 2021 - 2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.4.3. South Korea Market, by Procedure, 2021 - 2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By Product Type, 2021 - 2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, by Procedure, 2021 - 2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By Product Type, 2021 - 2030 (USD Million) 9.4.3. Latin America Market, by Procedure, 2021 - 2030 (USD Million) 9.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By Product Type, 2021 - 2030 (USD Million) 9.4.4.1.3. Brazil Market, by Procedure, 2021 - 2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By Product Type, 2021 - 2030 (USD Million) 9.4.4.2.3. Mexico Market, by Procedure, 2021 - 2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Market, By Product Type, 2021 - 2030 (USD Million) 9.4.4.3.3. Rest of the Latin America Market, by Procedure, 2021 - 2030 (USD Million) 9.5. MEA 9.5.1. MEA Market, By Product Type, 2021 - 2030 (USD Million) 9.5.3. MEA Market, by Procedure, 2021 - 2030 (USD Million) 10. Competitive Landscape 10.1 Integra LifeSciences. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Product Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Kangui Medical Innovation Co. Ltd. 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. AART Inc. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Anthony Products Inc. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Surgiform Technology Ltd 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. W.L. Gore & Associates, Inc. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. Stryker Corporation. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Spectrims Design Medicals Inc. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Eurosurgical Ltd. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Wanhe Plastic Materials. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. Hanson Medical, Inc. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. SientraIncKLS Martin L.P. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. DePuy Synthes. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. Medartis AG. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development 10.15. Lucid Implants. 10.15.1. Company overview 10.15.2. Financial performance 10.15.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development 10.16. Johnson & Johnson 10.16.1. Company overview 10.16.2. Financial performance 10.16.3. Product Portfolio Analysis 10.16.4. Business Strategy & Recent Development 10.17. TMJ Concepts. 10.17.1. Company overview 10.17.2. Financial performance 10.17.3. Product Portfolio Analysis 10.17.4. Business Strategy & Recent Development 10.18. Zimmer-Biomet Inc. 10.18.1. Company overview 10.18.2. Financial performance 10.18.3. Product Portfolio Analysis 10.18.4. Business Strategy & Recent Development 10.19. OsteoMed. 10.19.1. Company overview 10.19.2. Financial performance 10.19.3. Product Portfolio Analysis 10.19.4. Business Strategy & Recent Development 10.20. Implantech Associates, Inc. 10.20.1. Company overview 10.20.2. Financial performance 10.20.3. Product Portfolio Analysis 10.20.4. Business Strategy & Recent Development 10.21. Sebbin. 10.21.1. Company overview 10.21.2. Financial performance 10.21.3. Product Portfolio Analysis 10.21.4. Business Strategy & Recent Development List of Tables (65 Tables) TABLE 1. Market, By Product Type, 2021-2030 (USD Million) TABLE 2. Market FOR Chin & Mandibular, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Cheek, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Nasal, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Injectables, BY REGION, 2021-2030 (USD Million) TABLE 6. Market, BY PROCEDURE, 2021-2030 (USD Million) TABLE 7. Market FOR Eyelid Surgery, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Facelift Surgery, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Rhinoplasty, BY REGION, 2021-2030 (USD Million) TABLE 10. Market, BY REGION, 2021-2030 (USD Million) TABLE 11. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 12. NORTH AMERICA Market, BY Procedures, 2021-2030 (USD Million) TABLE 13. NORTH AMERICA Market, By Product Type, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA Market, BY PROCEDURE, 2021-2030 (USD Million) TABLE 15. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 16. EUROPE Market, By Product Type, 2021-2030 (USD Million) TABLE 17. EUROPE Market, BY PROCEDURE, 2021-2030 (USD Million) TABLE 18. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 19. ASIA-PACIFIC Market, By Product Type, 2021-2030 (USD Million) TABLE 20. ASIA-PACIFIC Market, BY PROCEDURE, 2021-2030 (USD Million) TABLE 21. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. LAMEA Market, By Product Type, 2021-2030 (USD Million) TABLE 23. LAMEA Market, BY PROCEDURE, 2021-2030 (USD Million) TABLE 24. Integra LifeSciences: COMPANY SNAPSHOT TABLE 25. Integra LifeSciences: OPERATING SEGMENTS TABLE 26. Kangui Medical Innovation Co. Ltd: COMPANY SNAPSHOT TABLE 27. Kangui Medical Innovation Co. Ltd: OPERATING SEGMENTS TABLE 28. AART Inc: COMPANY SNAPSHOT TABLE 29. AART Inc: OPERATING SEGMENTS TABLE 30. Anthony Products Inc: COMPANY SNAPSHOT TABLE 31. Anthony Products Inc: OPERATING SEGMENTS TABLE 32. Surgiform Technology Ltd: COMPANY SNAPSHOT TABLE 33. Surgiform Technology Ltd: OPERATING SEGMENTS TABLE 34. W.L. Gore & Associates, Inc: COMPANY SNAPSHOT TABLE 35. W.L. Gore & Associates, Inc: OPERATING SEGMENTS TABLE 36. Stryker Corporation: COMPANY SNAPSHOT TABLE 37. Stryker Corporation: OPERATING SEGMENTS TABLE 38. Spectrims Design Medicals Inc: COMPANY SNAPSHOT TABLE 39. Spectrims Design Medicals Inc: OPERATING SEGMENTS TABLE 40. Eurosurgical Ltd: COMPANY SNAPSHOT TABLE 41. Eurosurgical Ltd: OPERATING SEGMENTS TABLE 42. Wanhe Plastic Materials: COMPANY SNAPSHOT TABLE 43. Wanhe Plastic Materials: OPERATING SEGMENTS TABLE 44. Hanson Medical, Inc: COMPANY SNAPSHOT TABLE 45. Hanson Medical, Inc: OPERATING SEGMENTS TABLE 46. SientraIncKLS Martin L.P.: COMPANY SNAPSHOT TABLE 47. SientraIncKLS Martin L.P.: OPERATING SEGMENTS TABLE 48. DePuy Synthes: COMPANY SNAPSHOT TABLE 49. DePuy Synthes: OPERATING SEGMENTS TABLE 50. Medartis AG: COMPANY SNAPSHOT TABLE 51. Medartis AG: OPERATING SEGMENTS TABLE 52. Lucid Implants: COMPANY SNAPSHOT TABLE 53. Lucid Implants: OPERATING SEGMENTS TABLE 54. Johnson & Johnson: COMPANY SNAPSHOT TABLE 55. Johnson & Johnson: OPERATING SEGMENTS TABLE 56. TMJ Concepts: COMPANY SNAPSHOT TABLE 57. TMJ Concepts: OPERATING SEGMENTS TABLE 58. Zimmer-Biomet Inc: COMPANY SNAPSHOT TABLE 59. Zimmer-Biomet Inc: OPERATING SEGMENTS TABLE 60. OsteoMed: COMPANY SNAPSHOT TABLE 61. OsteoMed: OPERATING SEGMENTS TABLE 62. Implantech Associates, Inc: COMPANY SNAPSHOT TABLE 63. Implantech Associates, Inc: OPERATING SEGMENTS TABLE 64. Sebbin: COMPANY SNAPSHOT TABLE 65. Sebbin: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 21 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Facial Implants, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Facial Implants, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Procedures, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Product Type, 2019 vs. 2025 Figure 13 Geographical Snapshot of the Market Figure 14 Injectables to Witness Higher CAGR in Market for Product Type Segment during Forecast Period. Figure 15 Facelift Surgery to Witness Higher CAGR in Market for Procedure Segment during Forecast Period. Figure 16 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges Figure 18 North America: Market Snapshot Figure 19 Asia Pacific: Market Snapshot Figure 20 Vendor Dive: Evaluation Overview